Skip to main content
SpringerLink
Log in

RASSF Family

  • Living reference work entry
  • First Online:
Encyclopedia of Signaling Molecules

  • 130 Accesses

Leanne Bradley; Delia Koennig; and Maria Laura Tognoli are contributed equally to this work.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 2005;65(9):3497–508. doi:10.1158/0008-5472.CAN-04-4088.

    Article  CAS  PubMed  Google Scholar 

  • Akino K, Toyota M, Suzuki H, et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology. 2005;129(1):156–69. doi:10.1053/j.gastro.2005.03.051.

    Article  CAS  PubMed  Google Scholar 

  • Alam MR, Caldwell BD, Johnson RC, Darlington DN, Mains RE, Eipper BA. Novel proteins that interact with the COOH-terminal cytosolic routing determinants of an integral membrane peptide-processing enzyme. J Biol Chem. 1996;271(45):28636–40. doi:10.1074/jbc.271.45.28636.

    Article  CAS  PubMed  Google Scholar 

  • Allen NPC, Donninger H, Vos MD, et al. RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene. 2007;26(42):6203–11. doi:10.1038/sj.onc.1210440.

    Article  CAS  PubMed  Google Scholar 

  • Amaar YG, Baylink DJ, Mohan S. Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. J Bone Min Res. 2005;20(8):1430–9. doi:10.1359/JBMR.050311.

    Article  CAS  Google Scholar 

  • Amaar YG, Minera MG, Hatran LK, Strong DD, Mohan S, Reeves ME. Ras association domain family 1C protein stimulates human lung cancer cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2006;291(6):1185–1190

    Google Scholar 

  • Aoyama Y, Avruch J, Zhang X. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene. 2004;23(19):3426–33. doi:10.1038/sj.onc.1207486.

    Article  CAS  PubMed  Google Scholar 

  • Arnette C, Efimova N, Zhu X, Clark GJ, Kaverina I. Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity. Mol Biol Cell. 2014;25(6):800–10. doi:10.1091/mbc.E13-07-0374.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Arora P, Basu A, Schmidt ML, et al. NS5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication. Hepatology. 2017. doi:10.1002/hep.29049.

    PubMed  Google Scholar 

  • Astuti D, Agathanggelou A, Honorio S, et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene. 2001;20(51):7573–7. doi:10.1038/sj.onc.1204968.

    Article  CAS  PubMed  Google Scholar 

  • Avruch J, Praskova M, Ortiz-Vega S, Liu M, Zhang X-FF. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. Methods Enzym. 2006;407(2002):290–310. doi:10.1016/S0076-6879(05)07025-4.

    Article  CAS  Google Scholar 

  • Baksh S, Tommasi S, Fenton S, et al. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell. 2005;18(6):637–50. doi:10.1016/j.molcel.2005.05.010.

    Article  CAS  PubMed  Google Scholar 

  • Bee C, Moshnikova A, Mellor CD, et al. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation. J Biol Chem. 2010;285(21):16258–66. doi:10.1074/jbc.M109.081562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bergqvist J, Latif A, Roberts SA, et al. RASSF1A polymorphism in familial breast cancer. Fam Cancer. 2010;9(3):263–5. doi:10.1007/s10689-010-9335-8.

    Article  CAS  PubMed  Google Scholar 

  • Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation. 1998;97(14):1375–1381

    Google Scholar 

  • Burbee DG, Forgacs E, Zöchbauer-Müller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst. 2001;93(9):691–9. doi:10.1093/JNCI/93.9.691.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Camps C, Buffa FM, Colella S, et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res. 2008;14(5):1340–8. doi:10.1158/1078-0432.CCR-07-1755.

    Article  CAS  PubMed  Google Scholar 

  • Chang HW, Chan A, Kwong DLW, Wei WI, Sham JST, Yuen APW. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int J Cancer. 2003;105(6):851–5. doi:10.1002/ijc.11162.

    Article  CAS  PubMed  Google Scholar 

  • Chen L. P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha -amidating monooxygenase, is associated with endosomes. J Biol Chem. 1998;273(50):33524–32. doi:10.1074/jbc.273.50.33524.

    Article  CAS  PubMed  Google Scholar 

  • Chow LS, Lo KW, Kwong J, Wong AY, Huang DP. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma. Oncol Rep. 2004;12(4):781–7. https://www.ncbi.nlm.nih.gov/pubmed/15375500.

    CAS  PubMed  Google Scholar 

  • Comincini S, Castiglioni BM, Foti GM, Del Vecchio I, Ferretti L. Isolation and molecular characterization of rasfadin, a novel gene in the vicinity of the bovine prion gene. Mamm Genome. 2001;12(2):150–6.

    Article  CAS  PubMed  Google Scholar 

  • Cooper WN, Dickinson RE, Dallol A, et al. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. Oncogene. 2008;27(12):1805–11. doi:10.1038/sj.onc.1210805.

    Article  CAS  PubMed  Google Scholar 

  • Cooper WN, Hesson LB, Matallanas D, et al. RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene. 2009;28(33):2988–98. doi:10.1038/onc.2009.152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • da Costa PE, Cavalli LR, Rainho CA. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. Epigenetics. 2011;6(12):1413–24. doi:10.4161/epi.6.12.18271.

    Article  CAS  Google Scholar 

  • Dallol A, Agathanggelou A, Fenton SL, et al. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res. 2004;16:4112–6.

    Article  Google Scholar 

  • Dallol A, Hesson LB, Matallanas D, et al. RAN GTPase is a RASSF1A effector involved in controlling microtubule organization. Curr Biol. 2009;19(14):1227–32. doi:10.1016/j.cub.2009.05.064.

    Article  CAS  PubMed  Google Scholar 

  • Dammann R, Li C, Yoon J-HH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25(3):315–9. doi:10.1038/77083.

    Article  CAS  PubMed  Google Scholar 

  • Dammann R, Schagdarsurengin U, Strunnikova M, et al. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol. 2003a;18(2):665–77. http://www.ncbi.nlm.nih.gov/pubmed/12647816.

    CAS  PubMed  Google Scholar 

  • Dammann R, Schagdarsurengin U, Liu L, et al. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene. 2003b;22(24):3806–12. doi:10.1038/sj.onc.1206582.

    Article  CAS  PubMed  Google Scholar 

  • de Caceres II, Battagli C, Esteller M, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res. 2004;64(18):6476–81. doi:10.1158/0008-5472.CAN-04-1529.

    Article  Google Scholar 

  • Debeer P, Schoenmakers EFPM, Twal WO, et al. The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet. 2002;39(2):98–104. doi:10.1136/JMG.39.2.98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Delre D, Clark GJ. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest. 2010;120. doi:10.1172/JCI43569.

    Google Scholar 

  • Djos A, Martinsson T, Kogner P, Carén H. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Mol Cancer. 2012;11:40. doi:10.1186/1476-4598-11-40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donninger H, Vos MD, Clark GJ. The RASSF1A tumor suppressor. J Cell Sci. 2007;120(Pt 18):3163–72. doi:10.1242/jcs.010389.

    Article  CAS  PubMed  Google Scholar 

  • Donninger H, Hesson L, Vos M, et al. The Ras effector RASSF2 controls the PAR-4 tumor suppressor. Mol Cell Biol. 2010;30(11):2608–20. doi:10.1128/MCB.00208-09.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donninger H, Clark JA, Monaghan MK, Schmidt ML, Vos M, Clark GJ. Cell cycle restriction is more important than apoptosis induction for RASSF1A protein tumor suppression. J Biol Chem. 2014;289(45):31287–95. doi:10.1074/jbc.M114.609537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donninger H, Clark J, Rinaldo F, et al. The RASSF1A tumor suppressor regulates XPA-mediated DNA repair. Mol Cell Biol. 2015a;35(1):277–87. doi:10.1128/MCB.00202-14.

    Article  PubMed  CAS  Google Scholar 

  • Donninger H, Calvisi DF, Barnoud T, et al. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. J Cell Biol. 2015b;208(6):777–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A. 2001;98(13):7504–9. doi:10.1073/pnas.131216298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eckfeld K, Hesson L, Vos MD, Bieche I, Latif F, Clark GJ. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res. 2004;64(23):8688–93. doi:10.1158/0008-5472.CAN-04-2065.

    Article  CAS  PubMed  Google Scholar 

  • Endoh M, Tamura G, Honda T, et al. RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. Br J Cancer. 2005;93(12):1395–9. doi:10.1038/sj.bjc.6602854.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Escobar-Cabrera E, Lau DKW, Giovinazzi S, Ishov AM, McIntosh LP. Structural characterization of the DAXX N-terminal helical bundle domain and its complex with Rassf1C. Structure. 2010;18(12):1642–53. doi:10.1016/j.str.2010.09.016.

    Article  CAS  PubMed  Google Scholar 

  • Estrabaud E, Lassot I, Blot G, et al. RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of -catenin by interacting with TrCP. Cancer Res. 2007;67(3):1054–61. doi:10.1158/0008-5472.CAN-06-2530.

    Article  CAS  PubMed  Google Scholar 

  • Falvella FS, Manenti G, Spinola M, et al. Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene. 2006;25(28):3934–8. doi:10.1038/sj.onc.1209422.

    Article  CAS  PubMed  Google Scholar 

  • Fiegl H, Gattringer C, Widschwendter A, et al. Methylated DNA collected by tampons – a new tool to detect endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(5):882–8.

    CAS  PubMed  Google Scholar 

  • Foley CJ, Freedman H, Choo SL, et al. Dynamics of RASSF1A/MOAP-1 association with death receptors. Mol Cell Biol. 2008;28(14):4520–35. doi:10.1128/MCB.02011-07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Foukakis T, Au AYM, Wallin G, et al. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR γ fusion. J Clin Endocrinol Metab. 2006;91(3):1143–9. doi:10.1210/jc.2005-1372.

    Article  CAS  PubMed  Google Scholar 

  • Friess H, Ding J, Kleeff J, et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci C. 2003;60(6):1180–99. doi:10.1007/s00018-003-3036-5.

    Article  CAS  Google Scholar 

  • Fujita H, Fukuhara S, Sakurai A, et al. Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes. J Biol Chem. 2005;280(6):5022–31. doi:10.1074/jbc.M409701200.

    Article  CAS  PubMed  Google Scholar 

  • Fukatsu A, Ishiguro F, Tanaka I, et al. RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer. Lung Cancer. 2014;83(1):23–9. doi:10.1016/j.lungcan.2013.10.014.

    Article  PubMed  Google Scholar 

  • Gao BN, Xie XJ, Huang CX, et al. RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res. 2008;68(1):22–5. doi:10.1158/0008-5472.Can-07-5183.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Geli J, Kogner P, Lanner F, et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. Int J Cancer. 2008;123(2):389–94. doi:10.1002/ijc.23533.

    Article  CAS  PubMed  Google Scholar 

  • Giovinazzi S, Lindsay CR, Morozov VM, et al. Regulation of mitosis and taxane response by Daxx and Rassf1. Oncogene. 2012;31(1):13–26. doi:10.1038/onc.2011.211.

    Article  CAS  PubMed  Google Scholar 

  • Gordon M, El-Kalla M, Baksh S. RASSF1 polymorphisms in cancer. Mol Biol Int. 2012;2012:365213. doi:10.1155/2012/365213.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Grawenda AM, O’Neill E. Clinical utility of RASSF1A methylation in human malignancies. Br J Cancer. 2015;113(3):372–81. doi:10.1038/bjc.2015.221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gulsen T, Hadjicosti I, Li Y, Zhang X, Whitley PR, Chalmers AD. Truncated RASSF7 promotes centrosomal defects and cell death. Dev Biol. 2016;409(2):502–17. doi:10.1016/j.ydbio.2015.11.001.

    Article  CAS  PubMed  Google Scholar 

  • Guo C, Tommasi S, Liu L, Yee J-K, Dammann R, Pfeifer GP. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol. 2007;17(8):700–5. doi:10.1016/j.cub.2007.02.055.

    Article  CAS  PubMed  Google Scholar 

  • Guo W, Cui L, Wang C, et al. Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma. Clin Exp Metastasis. 2014;31(5):521–33. doi:10.1007/s10585-014-9646-5.

    Article  CAS  PubMed  Google Scholar 

  • Guo W, Dong Z, Guo Y, et al. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. Mol Carcinog. 2016;55(11):1655–66. doi:10.1002/mc.22416.

    Article  CAS  PubMed  Google Scholar 

  • Hamilton G, Yee KS, Scrace S, O’Neill E. ATM regulates a RASSF1A-dependent DNA damage response. Curr Biol. 2009;19(23):2020–5. doi:10.1016/j.cub.2009.10.040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Han Y, Dong Q, Hao J, et al. RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion. Tumour Biol. 2016;37(4):4865–71. doi:10.1007/s13277-015-4343-9.

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013.

    Article  CAS  PubMed  Google Scholar 

  • Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene. 2002;21(27):4345–9. doi:10.1038/sj.onc.1205446.

    Article  CAS  PubMed  Google Scholar 

  • Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits wnt signaling to restrain cardiomyocyte proliferation and heart size. Science (80- ). 2011;332(6028):458–61. doi:10.1126/science.1199010.

    Article  CAS  Google Scholar 

  • Helmbold P, Richter AM, Walesch S, et al. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi. J Invest Dermatol. 2012;132(3):687–94. doi:10.1038/jid.2011.380.

    Article  CAS  PubMed  Google Scholar 

  • Hesson L, Dallol A, Minna JD, Maher ER, Latif F. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene. 2003;22(6):947–54. doi:10.1038/sj.onc.1206191.

    Article  CAS  PubMed  Google Scholar 

  • Hesson L, Bièche I, Krex D, et al. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene. 2004;23(13):2408–19. doi:10.1038/sj.onc.1207407.

    Article  CAS  PubMed  Google Scholar 

  • Hesson LB, Wilson R, Morton D, et al. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene. 2005;24(24):3987–94. doi:10.1038/sj.onc.1208566.

    Article  CAS  PubMed  Google Scholar 

  • Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene. 2007;26(52):7283–301. doi:10.1038/sj.onc.1210547.

    Article  CAS  PubMed  Google Scholar 

  • Hesson LB, Dunwell TL, Cooper WN, et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer. 2009;8(1):42. doi:10.1186/1476-4598-8-42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hill VK, Underhill-Day N, Krex D, et al. Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis. Oncogene. 2011;30(8):978–89. doi:10.1038/onc.2010.471.

    Article  CAS  PubMed  Google Scholar 

  • Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 2004;64(15):5511–7. doi:10.1158/0008-5472.CAN-04-0799.

    Article  CAS  PubMed  Google Scholar 

  • Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA. 1995;273(7):558. doi:10.1001/jama.1995.03520310056030.

    Article  CAS  PubMed  Google Scholar 

  • Hwang E, Ryu K-S, Pääkkönen K, et al. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci U S A. 2007;104(22):9236–41. doi:10.1073/pnas.0610716104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikeda M, Hirabayashi S, Fujiwara N, et al. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways. Exp Cell Res. 2007;313(7):1484–95. doi:10.1016/j.yexcr.2007.02.013.

    Article  CAS  PubMed  Google Scholar 

  • Ikeda M, Kawata A, Nishikawa M, et al. Hippo pathway-dependent and -independent roles of RASSF6. Sci Signal. 2009;2(90):ra59. doi:10.1126/scisignal.2000300.

    Article  PubMed  Google Scholar 

  • Ishiguro K, Avruch J, Landry A, et al. Nore1B regulates TCR signaling via Ras and Carma1. Cell Signal. 2006;18(10):1647–54. doi:10.1016/j.cellsig.2006.01.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iwasa H, Kudo T, Maimaiti S, et al. The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein. J Biol Chem. 2013;288(42):30320–9. doi:10.1074/jbc.M113.507384.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacquemart IC, Springs AEB, Chen WY. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Int J Oncol. 2009;34(2):517–28.

    CAS  PubMed  Google Scholar 

  • James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGF beta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem. Development. 2005;132(6):1273–82. doi:10.1242/dev.01706.

    Article  CAS  PubMed  Google Scholar 

  • Jin J, Smith FD, Stark C, et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol. 2004;14(16):1436–50. doi:10.1016/j.cub.2004.07.051.

    Article  CAS  PubMed  Google Scholar 

  • Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683–92. doi:10.1016/j.cell.2007.01.029.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung HY, Jung JS, Whang YM, Kim YH, Jung Hae-Yun Jung Jun Seok WYMKYH. RASSF1A suppresses cell migration through inactivation of HDAC6 and increase of acetylated alpha-tubulin. Cancer Res Treat. 2013;45(2):134–44. doi:10.4143/crt.2013.45.2.134.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kaira K, Sunaga N, Tomizawa Y, et al. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. Int J Oncol. 2007. doi:10.3892/ijo.31.1.169.

    PubMed  Google Scholar 

  • Kanzaki H, Hanafusa H, Yamamoto H, et al. Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk. Cancer Lett. 2006;238(1):128–34. doi:10.1016/j.canlet.2005.07.006.

    Article  CAS  PubMed  Google Scholar 

  • Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol. 2003;4(8):741–8. doi:10.1038/ni950.

    Article  CAS  PubMed  Google Scholar 

  • Katagiri K, Imamura M, Kinashi T. Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion. Nat Immunol. 2006;7(9):919–28. doi:10.1038/ni1374.

    Article  CAS  PubMed  Google Scholar 

  • Kaverina I, Straube A. Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol. 2011;22(9):968–74. doi:10.1016/j.semcdb.2011.09.017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khokhlatchev A, Rabizadeh S, Xavier R, et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol. 2002;12(4):253–65. doi:10.1016/S0960-9822(02)00683-8.

    Article  CAS  PubMed  Google Scholar 

  • Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999;274(53):37538–43.

    Article  CAS  PubMed  Google Scholar 

  • Kim D-H, Kim JS, Park J-H, et al. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer. Cancer Res. 2003;63(19):6206–11.

    CAS  PubMed  Google Scholar 

  • Kita R, Fraser HB. Local adaptation of sun-exposure-dependent gene expression regulation in human skin. Tishkoff SA, ed. PLOS Genet. 2016;12(10):e1006382. doi:10.1371/journal.pgen.1006382.

    Google Scholar 

  • Kitagawa D, Kajiho H, Negishi T, et al. Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation. EMBO J. 2006;25(14):3286–97. doi:10.1038/sj.emboj.7601212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res. 1997;71:27–92.

    Article  CAS  PubMed  Google Scholar 

  • Kudo T, Ikeda M, Nishikawa M, et al. The RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell-cycle arrest via p53. Cancer Res. 2012;72(11):2901–11. doi:10.1158/0008-5472.CAN-12-0572.

    Article  CAS  PubMed  Google Scholar 

  • Kumari G, Singhal PK, Rao MRKS, Mahalingam S. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. J Mol Biol. 2007;367(5):1294–311. doi:10.1016/j.jmb.2007.01.026.

    Article  CAS  PubMed  Google Scholar 

  • Kumari G, Singhal PK, Suryaraja R, Mahalingam S. Functional interaction of the Ras effector RASSF5 with the tyrosine kinase lck: critical role in nucleocytoplasmic transport and cell cycle regulation. J Mol Biol. 2010;397(1):89–109. doi:10.1016/j.jmb.2010.01.005.

    Article  CAS  PubMed  Google Scholar 

  • Law J, Salla M, Zare A, et al. Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein. J Biol Chem. 2015;290(40):24100–18. doi:10.1074/jbc.M115.648345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CK, Lee J-H, Lee M-G, et al. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors. BMC Cancer. 2010;10:577. doi:10.1186/1471-2407-10-577.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee C-M, Yang P, Chen L-C, et al. A novel role of RASSF9 in maintaining epidermal homeostasis. Beier F, ed. PLoS One. 2011;6(3):e17867. doi:10.1371/journal.pone.0017867.

    Google Scholar 

  • Lee D, Park S-J, Sung KS, et al. Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1. EMBO Rep. 2012;13(2):163–9. doi:10.1038/embor.2011.235.

    Article  PubMed  CAS  Google Scholar 

  • Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60(21):6116–33.

    CAS  PubMed  Google Scholar 

  • Li J, Zhang Z, Dai Z, et al. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia. 2003;5(4):362–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li J, Wang F, Protopopov A, et al. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene. 2004;23(35):5941–9. doi:10.1038/sj.onc.1207789.

    Article  CAS  PubMed  Google Scholar 

  • Li X, Zhao G, Wang Y, Zhang J, Duan Z, Xin S. RASSF7 and RASSF8 proteins are predictive factors for development and metastasis in malignant thyroid neoplasms. J Cancer Res Ther. 2013;9 (Suppl 7):S173–7. doi:10.4103/0973–1482.122519.

    Google Scholar 

  • Lian I, Kim J, Okazawa H, et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 2010;24(11):1106–18. doi:10.1101/gad.1903310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liang G-P, Su Y-Y, Chen J, Yang Z-C, Liu Y-S, Luo X-D. Analysis of the early adaptive response of endothelial cells to hypoxia via a long serial analysis of gene expression. Biochem Biophys Res Commun. 2009;384:415–9. doi:10.1016/j.bbrc.2009.04.160.

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Katrin Baier RHD & GPP. The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase promoting complex. Cell Cycle. 2007;6(13):1663–5.

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Tommasi S, Lee D-H, Dammann R, Pfeifer GP. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene. 2003;22(50):8125–36. doi:10.1038/sj.onc.1206984.

    Article  CAS  PubMed  Google Scholar 

  • Liu Z-H, Huo J-L, Wu Z-G, et al. RASSF7 expression and its regulatory roles on apoptosis in human intervertebral disc degeneration. Int J Clin Exp Pathol. 2015;8(12):16097–103.

    PubMed  PubMed Central  Google Scholar 

  • Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 2001;61(10):3877–81.

    CAS  PubMed  Google Scholar 

  • Lock FE, Underhill-Day N, Dunwell T, et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways. Oncogene. 2010;29(30):4307–16. doi:10.1038/onc.2010.192.

    Article  CAS  PubMed  Google Scholar 

  • Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63(10):2649–57.

    CAS  PubMed  Google Scholar 

  • Lorenzato A, Martino C, Dani N, et al. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. FASEB J. 2012;26(6):2446–56. doi:10.1096/fj.11-195982.

    Article  CAS  PubMed  Google Scholar 

  • Lowe AW, Olsen M, Hao Y, et al. Gene expression patterns in pancreatic tumors, cells and tissues. PLoS One. 2007;2(3):1–11. doi:10.1371/journal.pone.0000323.

    Article  CAS  Google Scholar 

  • Macheiner D, Heller G, Kappel S, et al. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J Hepatol. 2006;45(1):81–9. doi:10.1016/j.jhep.2005.12.017.

    Article  CAS  PubMed  Google Scholar 

  • Malpeli G, Amato E, Dandrea M, et al. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1Cin pancreatic endocrine tumors. BMC Cancer. 2011;11(1):351. doi:10.1186/1471-2407-11-351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matallanas D, Romano D, Yee K, et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell. 2007;27(6):962–75. doi:10.1016/j.molcel.2007.08.008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matallanas D, Romano D, Al-Mulla F, et al. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol Cell. 2011;44(6):893–906. doi:10.1016/j.molcel.2011.10.016.

    Article  CAS  PubMed  Google Scholar 

  • Mezzanotte JJ, Hill V, Lee Schmidt M, et al. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells. Epigenetics. 2014;9(11):1496–503. doi:10.4161/15592294.2014.983361.

    Article  PubMed  PubMed Central  Google Scholar 

  • Michifuri Y, Hirohashi Y, Torigoe T, et al. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal. Biochem Biophys Res Commun. 2013;439(1):96–102. doi:10.1016/j.bbrc.2013.08.021.

    Article  CAS  PubMed  Google Scholar 

  • Morris MR, Hesson LB, Wagner KJ, et al. Multigene methylation analysis of Wilms’ tumour and adult renal cell carcinoma. Oncogene. 2003a;22(43):6794–801. doi:10.1038/sj.onc.1206914.

    Article  CAS  PubMed  Google Scholar 

  • Morris JA, Kandpal G, Ma L, Austin CP. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet. 2003b;12(13):1591–608. doi:10.1093/hmg/ddg162.

    Article  CAS  PubMed  Google Scholar 

  • Moshnikova A, Frye J, Shay JW, Minna JD, Khokhlatchev AV. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. J Biol Chem. 2006;281(12):8143–52. doi:10.1074/jbc.M511837200.

    Article  CAS  PubMed  Google Scholar 

  • Mutter GL, Baak JPA, Fitzgerald JT, et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001;83(2):177–85. doi:10.1006/gyno.2001.6352.

    Article  CAS  PubMed  Google Scholar 

  • Nakamura N, Carney JA, Jin L, et al. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Investig. 2005;85(9):1065–75. doi:10.1038/labinvest.3700306.

    Article  CAS  PubMed  Google Scholar 

  • Nakamura T, Yasuda S, Nagai H, et al. Longest neurite-specific activation of Rap1B in hippocampal neurons contributes to polarity formation through RalA and Nore1A in addition to PI3-kinase. Genes to Cells. 2013;18(11):1020–31. doi:10.1111/gtc.12097.

    Article  CAS  PubMed  Google Scholar 

  • Newton AC. Protein kinase C. Seeing two domains. Curr Biol. 1995;5(9):973–6. doi:10.1016/S0960-9822(95)00191-6.

    Article  CAS  PubMed  Google Scholar 

  • Nosho K, Yamamoto H, Takahashi T, et al. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers. Carcinogenesis. 2007;28(6):1364–70. doi:10.1093/carcin/bgl246.

    Article  CAS  PubMed  Google Scholar 

  • Nybakken K, Vokes SA, Lin TY, McMahon AP, Perrimon N. A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway. Nat Genet. 2005;37. doi:10.1038/ng1682.

    Google Scholar 

  • Oceandy D, Pickard A, Prehar S, et al. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation. 2009;120(7):607–U125. doi:10.1161/Circulationaha.109.868554.

    Article  CAS  PubMed  Google Scholar 

  • Ortiz-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene. 2002;21(9):1381–90. doi:10.1038/sj.onc.1205192.

    Article  CAS  PubMed  Google Scholar 

  • Park H-W, Kang HC, Kim I-J, et al. Correlation between hypermethylation of theRASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers. Int J Cancer. 2007;120(1):7–12. doi:10.1002/ijc.22276.

    Article  CAS  PubMed  Google Scholar 

  • Park J, Kang SI, Lee S-Y, et al. Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis. J Biol Chem. 2010;285(45):35029–38. doi:10.1074/jbc.M110.165506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pefani DE, Latusek R, Pires I, et al. RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2. Nat Cell Biol. 2014. doi:10.1038/ncb3035.

    PubMed  PubMed Central  Google Scholar 

  • Pefani DE, Pankova D, Abraham AG, et al. TGF-beta targets the hippo pathway scaffold RASSF1A to facilitate YAP/SMAD2 nuclear translocation. Mol Cell. 2016;63(1):156–66. doi:10.1016/j.molcel.2016.05.012.

    Article  CAS  PubMed  Google Scholar 

  • Pelosi G, Fumagalli C, Trubia M, et al. Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res. 2010;30(10):4269–81. http://www.ncbi.nlm.nih.gov/pubmed/21036752.

    CAS  PubMed  Google Scholar 

  • Ponting CP, Benjamin DR. A novel family of Ras-binding domains. Trends Biochem Sci. 1996;21(11):422–5. http://www.ncbi.nlm.nih.gov/pubmed/8987396.

    Article  CAS  PubMed  Google Scholar 

  • Porteous DJ, Millar JK, Brandon NJ, Sawa A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med. 2011;17(12):699–706. doi:10.1016/j.molmed.2011.09.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J. 2004;381(Pt 2):453–62. doi:10.1042/BJ20040025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rabizadeh S, Xavier RJ, Ishiguro K, et al. The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem. 2004;279(28):29247–54. doi:10.1074/jbc.M401699200.

    Article  CAS  PubMed  Google Scholar 

  • Recino A, Sherwood V, Flaxman A, et al. Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis. Biochem J. 2010;430(2):207–13. doi:10.1042/BJ20100883.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reeves N, Posakony JW. Genetic programs activated by proneural proteins in the developing Drosophila PNS. Dev Cell. 2005;8. doi:10.1016/j.devcel.2005.01.020.

    Google Scholar 

  • Reeves ME, Baldwin SW, Baldwin ML, et al. Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis. BMC Cancer. 2010;10:562. doi:10.1186/1471-2407-10-562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reeves ME, Baldwin ML, Aragon R, et al. RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1. BMC Res Notes. 2012;5:239. doi:10.1186/1756-0500-5-239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reeves ME, Firek M, Chen S-TT, Amaar Y. The RASSF1 gene and the opposing effects of the RASSF1A and RASSF1C isoforms on cell proliferation and apoptosis. Mol Biol Int. 2013;2013:145096. doi:10.1155/2013/145096.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Reeves MME, Firek M, Chen S-TS-TTS, et al. Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels. Pallante P, ed. PLoS One. 2014;9(7):e101679. doi:10.1371/journal.pone.0101679.

    Article  PubMed  PubMed Central  Google Scholar 

  • Reifenberger J, Knobbe CB, Sterzinger AA, et al. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int J Cancer. 2004;109(3):377–84. doi:10.1002/ijc.11722.

    Article  CAS  PubMed  Google Scholar 

  • Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta. 2009;1796(2):114–28. doi:10.1016/j.bbcan.2009.03.004.

    CAS  PubMed  Google Scholar 

  • Richter AM, Walesch SK, Würl P, Taubert H, Dammann RH. The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer. Oncogenesis. 2012;1(6):e18. doi:10.1038/oncsis.2012.18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richter AM, Zimmermann T, Haag T, Walesch SK, Dammann RH. Promoter methylation status of Ras-association domain family members in pheochromocytoma. Front Endocrinol. 2015;6:21. doi:10.3389/fendo.2015.00021.

    Article  Google Scholar 

  • Rodriguez-Viciana P, Sabatier C, McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol. 2004;24(11):4943–54. doi:10.1128/MCB.24.11.4943-4954.2004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rong R, Jin W, Zhang J, Saeed Sheikh M, Huang Y. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene. 2004;23(50):8216–30. doi:10.1038/sj.onc.1207901.

    Article  CAS  PubMed  Google Scholar 

  • Rong R, Jiang LY, Sheikh MS, Huang Y. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation. Oncogene. 2007;26(55):7700–8. doi:10.1038/sj.onc.1210575.

    Article  CAS  PubMed  Google Scholar 

  • Rykova EY, Skvortsova TE, Hoffmann AL, et al. Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood. Biochem Suppl Ser B Biomed Chem. 2008;2(2):208–13. doi:10.1134/S1990750808020133.

    Google Scholar 

  • Sánchez-Tomé E, Rivera B, Perea J, et al. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X. J Gastroenterol. 2015;50(6):657–66. doi:10.1007/s00535-014-1009-0.

    Article  PubMed  CAS  Google Scholar 

  • Schagdarsurengin U, Richter AM, Wöhler C, Dammann RH. Frequent epigenetic inactivation of RASSF10 in thyroid cancer. Epigenetics. 2009;4(8):571–6. doi:10.4161/epi.4.8.10056.

    Article  CAS  PubMed  Google Scholar 

  • Scheel H, Hofmann K. A novel inter action motif, SARAH, connects three classes of tumor suppressor. Curr Biol. 2003;13(23):R899–900. doi:10.1016/j.cub.2003.11.007.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt M, Calvisi D, Clark G. NORE1A regulates MDM2 via β-TrCP. Cancers (Basel). 2016;8(4):39. doi:10.3390/cancers8040039.

    Article  Google Scholar 

  • Sekido, Y., Ahmadian, M., II, W., Latif, F., Bader, S., Wei, M. H., … Minna, J. D. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene, 1998;16(24):3151–3157. http://doi.org/10.1038/sj.onc.1201858.

  • Sherwood V, Manbodh R, Sheppard C, ADC. RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. Mol Biol Cell. 2008;19(4):1772–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22(12):4309–18. http://www.ncbi.nlm.nih.gov/pubmed/12024041.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Song MS, Song SJ, Kim SY, Oh HJ, Lim DS. The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J. 2008;27(13):1863–74. doi:10.1038/emboj.2008.115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Song SJ, Song MS, Kim SJ, et al. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity. Cancer Res. 2009;69(6):2314–23.

    Article  CAS  PubMed  Google Scholar 

  • Song H, Oh S, Oh HJ, Lim D-S. Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. Biochem Biophys Res Commun. 2010;391(1):969–73. doi:10.1016/j.bbrc.2009.11.175.

    Article  CAS  PubMed  Google Scholar 

  • Steiner G, Cairns P, Polascik TJ, et al. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1–32.2. Cancer Res. 1996;56(21):5044–6.

    CAS  PubMed  Google Scholar 

  • Strano S, Monti O, Pediconi N, et al. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell. 2005;18(4):447–59. doi:10.1016/j.molcel.2005.04.008.

    Article  CAS  PubMed  Google Scholar 

  • Sun M, Chen M, Dawood F, et al. Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115(11):1398–1407

    Google Scholar 

  • Sundaresan V, Ganly P, Hasleton P, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 1992;7(10):1989–97.

    CAS  PubMed  Google Scholar 

  • Sup Song M, Sook Chang J, Jeong Song S, Hong Yang T, Lee H, Lim D-S. The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles. J Biol Chem. 2004. doi:10.1074/jbc.M409115200.

    Google Scholar 

  • Suryaraja R, Anitha M, Anbarasu K, Kumari G, Mahalingam S, Ca I. The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner. Cell Death Dis. 2013;4(3):e565. doi:10.1038/cddis.2013.91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takahashi S, Ebihara A, Kajiho H, Kontani K, Nishina H, Katada T. RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7. Cell Death Differ. 2011;18(4):645–55. doi:10.1038/cdd.2010.137.

    Article  CAS  PubMed  Google Scholar 

  • Tan DSP, Lambros MBK, Rayter S, et al. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res. 2009;15(7):2269–80. doi:10.1158/1078-0432.CCR-08-2403.

    Article  CAS  PubMed  Google Scholar 

  • Teng IW, Hou PC, Lee KD, et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 2011;71(13):4653–63. doi:10.1158/0008-5472.CAN-10-3418.

    Article  CAS  PubMed  Google Scholar 

  • Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 2009;69(5):1748–57.

    Article  CAS  PubMed  Google Scholar 

  • Tommasi S, Dammann R, Jin S-GG, Zhang XF, Avruch J, Pfeifer GP. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene. 2002;21(17):2713–20. doi:10.1038/sj/onc/1205365.

    Article  CAS  PubMed  Google Scholar 

  • Tommasi S, Dammann R, Zhang Z, et al. Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 2005;65(1):92 LP-98.

    Google Scholar 

  • Topaloglu O, Hoque MO, Tokumaru Y, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res. 2004;10(7):2284–8.

    Article  CAS  PubMed  Google Scholar 

  • Underhill-Day N, Hill V, Latif F. N-terminal RASSF family: RASSF7-RASSF10. Epigenetics. 2011;6(3):284–92. doi:10.4161/epi.6.3.14108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van der Weyden L, Adams DJ. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta. 2007;1776(1):58–85. doi:10.1016/j.bbcan.2007.06.003.

    PubMed  PubMed Central  Google Scholar 

  • van der Weyden L, Tachibana KK, Gonzalez MA, et al. The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol. 2005;25(18):8356–67. doi:10.1128/MCB.25.18.8356-8367.2005.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • van Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene. 2002;21(23):3792–5. doi:10.1038/sj.onc.1205466.

    Article  PubMed  Google Scholar 

  • van Hemert MJ, Steensma HY, van Heusden GPH. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. BioEssays. 2001;23(10):936–46. doi:10.1002/bies.1134.

    Article  PubMed  Google Scholar 

  • Varelas X, Sakuma R, Samavarchi-Tehrani P, et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol. 2008;10(7):837–48. doi:10.1038/ncb1748.

    Article  CAS  PubMed  Google Scholar 

  • Vasseur S, Malicet C, Calvo EL, et al. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene. Mol Cancer. 2003;2(1):19. doi:10.1186/1476-4598-2-19.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vavvas D, Li X, Avruch J, Zhang X-F. Identification of Nore1 as a potential Ras effector. J Biol Chem. 1998;273(10):5439–42. doi:10.1074/jbc.273.10.5439.

    Article  CAS  PubMed  Google Scholar 

  • Vlahov N, Scrace S, Soto MS, et al. Alternate RASSF1 transcripts control SRC activity, E-cadherin contacts, and YAP-mediated invasion. Curr Biol. 2015;25:1–16. doi:10.1016/j.cub.2015.09.072.

    Google Scholar 

  • Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem. 2000;275(46):35669–72. doi:10.1074/jbc.C000463200.

    Article  CAS  PubMed  Google Scholar 

  • Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem. 2003a;278(30):28045–51. doi:10.1074/jbc.M300554200.

    Article  CAS  PubMed  Google Scholar 

  • Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem. 2003b;278(24):21938–43. doi:10.1074/jbc.M211019200.

    Article  CAS  PubMed  Google Scholar 

  • Vos MD, Martinez A, Elam C, et al. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 2004;64(12):4244–4250.

    Google Scholar 

  • Vos MD, Dallol A, Eckfeld K, et al. The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem. 2006;281. doi:10.1074/jbc.M512128200.

    Google Scholar 

  • Wang J, Hua W, Huang SK, et al. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Oncotarget. 2015;6(30):30165–77. doi:10.18632/oncotarget.5030.

    PubMed  PubMed Central  Google Scholar 

  • Wang S, Liang Q, Qiao H, et al. DISC1 regulates astrogenesis in the embryonic brain via modulation of RAS/MEK/ERK signaling through RASSF7. Development. 2016;143(15):2732–40. doi:10.1242/dev.133066.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Yu A, Yu F-X. The Hippo pathway in tissue homeostasis and regeneration. Protein Cell. 2017. doi:10.1007/s13238-017-0371-0.

    Google Scholar 

  • Weitzel JN, Kasperczyk A, Mohan C, Krontiris TG. The HRAS1 gene cluster: two upstream regions recognizing transcripts and a third encoding a gene with a leucine zipper domain. Genomics. 1992;14(2):309–19. doi:10.1016/s0888-7543(05)80221-6.

    Article  CAS  PubMed  Google Scholar 

  • Wen Y, Wang Q, Zhou C, et al. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Ann Surg Oncol. 2011;7–11. doi:10.1245/s10434–011–1668-5.

    Google Scholar 

  • Wistuba II, Bryant D, Behrens C, et al. Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin Cancer Res. 1999;5(5):991–1000.

    CAS  PubMed  Google Scholar 

  • Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60(7):1949–60.

    CAS  PubMed  Google Scholar 

  • Yamamoto T, Taya S, Kaibuchi K. Ras-induced transformation and signaling pathway. J Biochem. 1999;126(5):799–803. http://www.ncbi.nlm.nih.gov/pubmed/10544270.

    Article  CAS  PubMed  Google Scholar 

  • Yee KS, Grochola L, Hamilton G, et al. A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma. Cancer Res. 2012;72(9):2206–17. doi:10.1158/0008-5472.CAN-11-2906.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95(5):1247–1252

    Google Scholar 

  • Zhang Z, Sun D, Van DN, Tang A, Hu L, Huang G. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer. 2007;120(1):32–8. doi:10.1002/ijc.22185.

    Article  CAS  PubMed  Google Scholar 

  • Zhang M, Wang D, Zhu T, Yin R. RASSF4 overexpression inhibits the proliferation, invasion, EMT, and wnt signaling pathway in osteosarcoma cells. Oncol Res. 2017;25(1):83–91. doi:10.3727/096504016X14719078133447.

    Article  PubMed  Google Scholar 

  • Zhou X, Li T-T, Feng X, et al. Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage. Biochem J. 2012;441(1):227–236

    Google Scholar 

  • Zhou X-H, Yang C-Q, Zhang C-L, Gao Y, Yuan H-B, Wang C. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling. Oncol Rep. 2014. doi:10.3892/or.2014.3387.

    Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK

      Leanne Bradley, Delia Koennig, Maria Laura Tognoli, Jelte van der Vaart & Eric O’Neill

    Authors
    1. Leanne Bradley
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Delia Koennig
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Maria Laura Tognoli
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Jelte van der Vaart
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Eric O’Neill
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Eric O’Neill .

    Editor information

    Editors and Affiliations

    1. Dept. Biological Science, Department of Molecular Science and Tech College of Natural Science, Suwon, Korea (Republic of)

      Sangdun Choi

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2017 Springer Science+Business Media LLC

    About this entry

    Cite this entry

    Bradley, L., Koennig, D., Tognoli, M.L., van der Vaart, J., O’Neill, E. (2017). RASSF Family. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6438-9_101852-1

    Download citation

    • DOI: https://doi.org/10.1007/978-1-4614-6438-9_101852-1

    • Received:

    • Accepted:

    • Published:

    • Publisher Name: Springer, New York, NY

    • Print ISBN: 978-1-4614-6438-9

    • Online ISBN: 978-1-4614-6438-9

    • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

    Publish with us

    Policies and ethics

    Search

    Navigation